Home/Vitara Biomedical/Noah Bartsch

NB

Noah Bartsch

EVP Clinical, Regulatory and Quality

Vitara Biomedical

Therapeutic Areas

Neonatology Premature Birth

Vitara Biomedical Pipeline

Drug	Indication	Phase
EXTEND	Support for extremely premature newborns (e.g., 22-28 weeks gestation) to improve survival and reduce severe morbidity	Pre-clinical / Early Feasibility

Leadership Team at Vitara Biomedical

Chief Executive Officer (CEO)

Co-Inventor, Medical Advisor

Co-Inventor, VP Preclinical Research

Neonatology Advisor

Chief Operations Officer

View full Vitara Biomedical profile